Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018-2022
Immune checkpoint inhibitors (ICI) have transformed the management of cancer, particularly for older adults, who constitute a majority of the global cancer patient population. This study aimed to assess the inclusion, characteristics, and reporting of…